Nov 05, 2025 • Zacks Commentary
NEUTRAL
Perrigo Q3 Earnings Beat, Sales Miss, Stock Falls on '25 View Cut
PRGO beats Q3 earnings estimates but misses on sales. It also trims the 2025 outlook and launches a strategic review of its infant formula unit.
Nov 05, 2025 • Motley Fool
SOMEWHAT-BULLISH
Perrigo ( PRGO ) Q3 2025 Earnings Call Transcript
Image source: The Motley Fool.Wednesday, Nov. 5, 2025 at 8:30 a.m. ETChief Executive Officer - Patrick Lockwood-TaylorContinue reading ...
Nov 05, 2025 • Zacks Commentary
NEUTRAL
Perrigo ( PRGO ) Q3 Earnings Surpass Estimates
Perrigo (PRGO) delivered earnings and revenue surprises of +6.67% and -4.84%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Oct 30, 2025 • Zacks Commentary
NEUTRAL
Insulet ( PODD ) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Insulet (PODD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Oct 29, 2025 • Zacks Commentary
NEUTRAL
Earnings Preview: Perrigo ( PRGO ) Q3 Earnings Expected to Decline
Perrigo (PRGO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Oct 15, 2025 • Benzinga
NEUTRAL
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks With Over 3% Dividend Yields - Pfizer ( NYSE:PFE ) , Bristol-Myers Squibb ( NYSE:BMY )
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.